p53 mutations occur in aggressive breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The p53 gene is a critical tumor suppressor.
• Mutations in specific p53 gene exons are common in human cancers.
• Exons 5-9 of the p53 gene are frequently targeted by acquired mutations.

Purpose of the Study:

• To investigate the frequency and types of p53 gene mutations in human primary breast tumors.
• To correlate p53 gene mutations with clinical and molecular features of breast cancer, such as receptor status and DNA amplification.

Main Methods:

• Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was used.
• 96 human primary breast tumors were analyzed for mutations in p53 gene exons 2, 5, 6, 7, 8, and 9.
• Mutations were characterized by nucleotide substitutions and allele loss.

Main Results:

• Mutations in the p53 gene were detected in 18.7% (18/96) of the breast tumors.
• The majority of mutations were single nucleotide substitutions, with a prevalence of G:C to A:T transitions.
• p53 mutations were significantly correlated with estrogen and/or progesterone receptor-negative breast tumors, indicative of aggressive cancer phenotypes.

Conclusions:

• p53 gene mutations are frequent in primary breast tumors and are associated with aggressive tumor subtypes.
• The findings highlight the role of p53 gene alterations in breast cancer development and progression.
• The study suggests p53 mutation status may serve as a biomarker for aggressive breast cancer.